Abstract P533: Incidence and Outcomes of Thrombectomy Rescue Therapies in Acute Basilar Artery Occlusions
BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). ObjectiveTo compare conventional and revised definitions of hematoma expa...
Saved in:
Published in | Stroke (1970) Vol. 52; no. Suppl_1; p. AP533 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Lippincott Williams & Wilkins
01.03.2021
|
Online Access | Get full text |
ISSN | 0039-2499 1524-4628 |
DOI | 10.1161/str.52.suppl_1.P533 |
Cover
Abstract | BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). ObjectiveTo compare conventional and revised definitions of hematoma expansion (HE), while accounting for WOC. MethodsWe analyzed data from the ATACH-2 trial, comparing revised definitions of HE incorporating intraventricular hemorrhage (IVH) expansion to the conventional definition of “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale of 4-6 at 90-days. We calculated the incidence, sensitivity, specificity, positive and negative predictive values, and c-statistic for all definitions of HE. Definitions were compared using non-parametric methods. Secondary analyses were performed after removing patients who experienced WOC. ResultsPrimary analysis included 948 patients. Using the conventional definition, the sensitivity was 37.1% and specificity was 83.2% for the primary outcome. Sensitivity improved with all three revised definitions (53.3%, 48.7%, and 45.3%, respectively), with minimal change to specificity (78.4%, 80.5%, and 81.0%, respectively). The greatest improvement was seen with the definition “≥6 mL or ≥33% or any IVH”, with increased c-statistic from 60.2% to 65.9% (p < 0.001). Secondary analysis excluded 46 participants who experienced WOC. The revised definitions outperformed the conventional definition in this population as well, with the greatest improvement in c-statistic using “≥6 mL or ≥33% or any IVH” (58.1% vs 64.1%, p < 0.001). ConclusionsHE definitions incorporating intraventricular expansion outperformed conventional definitions for predicting poor outcome, even after accounting for care limitations. |
---|---|
AbstractList | BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). ObjectiveTo compare conventional and revised definitions of hematoma expansion (HE), while accounting for WOC. MethodsWe analyzed data from the ATACH-2 trial, comparing revised definitions of HE incorporating intraventricular hemorrhage (IVH) expansion to the conventional definition of “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale of 4-6 at 90-days. We calculated the incidence, sensitivity, specificity, positive and negative predictive values, and c-statistic for all definitions of HE. Definitions were compared using non-parametric methods. Secondary analyses were performed after removing patients who experienced WOC. ResultsPrimary analysis included 948 patients. Using the conventional definition, the sensitivity was 37.1% and specificity was 83.2% for the primary outcome. Sensitivity improved with all three revised definitions (53.3%, 48.7%, and 45.3%, respectively), with minimal change to specificity (78.4%, 80.5%, and 81.0%, respectively). The greatest improvement was seen with the definition “≥6 mL or ≥33% or any IVH”, with increased c-statistic from 60.2% to 65.9% (p < 0.001). Secondary analysis excluded 46 participants who experienced WOC. The revised definitions outperformed the conventional definition in this population as well, with the greatest improvement in c-statistic using “≥6 mL or ≥33% or any IVH” (58.1% vs 64.1%, p < 0.001). ConclusionsHE definitions incorporating intraventricular expansion outperformed conventional definitions for predicting poor outcome, even after accounting for care limitations. Abstract only Background: Hematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). Objective: To compare conventional and revised definitions of hematoma expansion (HE), while accounting for WOC. Methods: We analyzed data from the ATACH-2 trial, comparing revised definitions of HE incorporating intraventricular hemorrhage (IVH) expansion to the conventional definition of “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale of 4-6 at 90-days. We calculated the incidence, sensitivity, specificity, positive and negative predictive values, and c- statistic for all definitions of HE. Definitions were compared using non-parametric methods. Secondary analyses were performed after removing patients who experienced WOC. Results: Primary analysis included 948 patients. Using the conventional definition, the sensitivity was 37.1% and specificity was 83.2% for the primary outcome. Sensitivity improved with all three revised definitions (53.3%, 48.7%, and 45.3%, respectively), with minimal change to specificity (78.4%, 80.5%, and 81.0%, respectively). The greatest improvement was seen with the definition “≥6 mL or ≥33% or any IVH”, with increased c -statistic from 60.2% to 65.9% (p < 0.001). Secondary analysis excluded 46 participants who experienced WOC. The revised definitions outperformed the conventional definition in this population as well, with the greatest improvement in c -statistic using “≥6 mL or ≥33% or any IVH” (58.1% vs 64.1%, p < 0.001). Conclusions: HE definitions incorporating intraventricular expansion outperformed conventional definitions for predicting poor outcome, even after accounting for care limitations. |
Author | Walker, Greg B Guenego, Adrien Guillen, Maud Piotin, Michel FAHED, Robert Lun, Ronda Benali, Amel Ducroux, Celina vannier, stephane Eugene, Francois Detraz, Lili Dargazanli, Cyril Haddad, John Aubertin, Mathilde Weisenburger-Lile, David Richard, Sebastien Lapergue, Bertrand heran, navraj s Lucas, Ludovic BLANC, RAPHAEL Labreuche, Julien Bourcier, Romain Maier, Benjamin Marnat, Gaultier Gory, Benjamin Siu, William |
AuthorAffiliation | Chu Nantes HGRL, Saint Herblain, France Vancouver, Canada FOCH Hosp, Suresnes, France Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France Neurovascular Unit, Foch Hosp–Suresnes, Suresnes, France Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France Lille, France CHRU NANCY, Nancy, France Rothschild Foundation, Paris, France Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France The Ottawa Hosp, Ottawa, Canada Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada Fraser Health Authority, New Westminster, Canada Dept of Neuroradiology, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France RENNES, France Dept of Medicine: Div of Neurology, Stroke Program, Université de Lorraine, CHRU-Nancy, F-54000 Nancy, France, France Neurovascular Unit, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France PIERRE PAUL RIQUET HOSPITAL, Toulouse, France Doctor of Medicine Program, Univ of Ottawa, Ottawa, |
AuthorAffiliation_xml | – name: RENNES, France – name: Dept of Neuroradiology, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France – name: CHRU NANCY, Nancy, France – name: Lille, France – name: Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France – name: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France – name: Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada – name: PIERRE PAUL RIQUET HOSPITAL, Toulouse, France – name: Dept of Medicine: Div of Neurology, Stroke Program, Université de Lorraine, CHRU-Nancy, F-54000 Nancy, France, France – name: Doctor of Medicine Program, Univ of Ottawa, Ottawa, Canada – name: Fraser Health Authority, New Westminster, Canada – name: The Ottawa Hosp, Ottawa, Canada – name: Neurovascular Unit, Foch Hosp–Suresnes, Suresnes, France – name: Chu Nantes HGRL, Saint Herblain, France – name: Dept of Diagnostic and Therapeutic Neuroradiology, Univ Hosp of Nantes, L’institut du thorax, Nantes, France – name: Vancouver, Canada – name: Neurovascular Unit, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France – name: Rothschild Foundation, Paris, France – name: Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France – name: FOCH Hosp, Suresnes, France |
Author_xml | – sequence: 1 givenname: Ronda surname: Lun fullname: Lun, Ronda organization: Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada – sequence: 2 givenname: Greg B surname: Walker fullname: Walker, Greg B organization: Vancouver, Canada – sequence: 3 givenname: David surname: Weisenburger-Lile fullname: Weisenburger-Lile, David organization: Neurovascular Unit, Foch Hosp–Suresnes, Suresnes, France – sequence: 4 givenname: Bertrand surname: Lapergue fullname: Lapergue, Bertrand organization: FOCH Hosp, Suresnes, France – sequence: 5 givenname: Adrien surname: Guenego fullname: Guenego, Adrien organization: PIERRE PAUL RIQUET HOSPITAL, Toulouse, France – sequence: 6 givenname: navraj s surname: heran fullname: heran, navraj s organization: Fraser Health Authority, New Westminster, Canada – sequence: 7 givenname: William surname: Siu fullname: Siu, William organization: Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada – sequence: 8 givenname: Cyril surname: Dargazanli fullname: Dargazanli, Cyril organization: Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France – sequence: 9 givenname: Amel surname: Benali fullname: Benali, Amel organization: Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France – sequence: 10 givenname: Benjamin surname: Gory fullname: Gory, Benjamin organization: CHRU NANCY, Nancy, France – sequence: 11 givenname: Sebastien surname: Richard fullname: Richard, Sebastien organization: Dept of Medicine: Div of Neurology, Stroke Program, Université de Lorraine, CHRU-Nancy, F-54000 Nancy, France, France – sequence: 12 givenname: Celina surname: Ducroux fullname: Ducroux, Celina organization: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France – sequence: 13 givenname: Michel surname: Piotin fullname: Piotin, Michel organization: Rothschild Foundation, Paris, France – sequence: 14 givenname: RAPHAEL surname: BLANC fullname: BLANC, RAPHAEL organization: Rothschild Foundation, Paris, France – sequence: 15 givenname: Julien surname: Labreuche fullname: Labreuche, Julien organization: Lille, France – sequence: 16 givenname: Ludovic surname: Lucas fullname: Lucas, Ludovic organization: Neurovascular Unit, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France – sequence: 17 givenname: John surname: Haddad fullname: Haddad, John organization: Doctor of Medicine Program, Univ of Ottawa, Ottawa, Canada – sequence: 18 givenname: Mathilde surname: Aubertin fullname: Aubertin, Mathilde organization: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France – sequence: 19 givenname: stephane surname: vannier fullname: vannier, stephane organization: RENNES, France – sequence: 20 givenname: Maud surname: Guillen fullname: Guillen, Maud organization: Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France – sequence: 21 givenname: Francois surname: Eugene fullname: Eugene, Francois organization: Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France – sequence: 22 givenname: Benjamin surname: Maier fullname: Maier, Benjamin organization: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France – sequence: 23 givenname: Gaultier surname: Marnat fullname: Marnat, Gaultier organization: Dept of Neuroradiology, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France – sequence: 24 givenname: Lili surname: Detraz fullname: Detraz, Lili organization: Chu Nantes HGRL, Saint Herblain, France – sequence: 25 givenname: Romain surname: Bourcier fullname: Bourcier, Romain organization: Dept of Diagnostic and Therapeutic Neuroradiology, Univ Hosp of Nantes, L’institut du thorax, Nantes, France – sequence: 26 givenname: Robert surname: FAHED fullname: FAHED, Robert organization: The Ottawa Hosp, Ottawa, Canada |
BookMark | eNotkN1qwzAMhc3oYG23J9iNXyCZbMeJs7us7KdQ6Bi9N46j0Gz5w04offu5tFcSQp90zlmRRT_0SMgzg5ixlL34ycWSx34ex1az-FsKcUeWTPIkSlKuFmQJIPKIJ3n-QFbe_wIAF0ouSVOUATZ2ohfolW5721TYW6Smr-h-nuzQoadDTQ9HN3Ql2mnozvQHvZ0xzNCZsQkLTU8LO09I34xvWuNo4SZ0Z7q3tp19M_T-kdzXpvX4dKtrcvh4P2y-ot3-c7spdpFVuYqErZJMyISlRiqDeWnylPOSJxnjJdQmy7DMpeIceCLq0Fc1pLwGFWhWohRrIq5nrRu8d1jr0TWdcWfNQF_C0sGvllzfwtIX34FKrtRpaINu_9fOJ3T6iKadjjqkBVmaQRS-MhAALAKQSol_N1lyYQ |
ContentType | Journal Article |
Copyright | Lippincott Williams & Wilkins |
Copyright_xml | – notice: Lippincott Williams & Wilkins |
DBID | AAYXX CITATION |
DOI | 10.1161/str.52.suppl_1.P533 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | AP533 |
ExternalDocumentID | 10_1161_str_52_suppl_1_P533 00007670-202103001-00588 |
GroupedDBID | --- .XZ .Z2 01R 0R~ 123 1J1 2WC 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAUEB AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFS ACGOD ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADGGA ADHPY AE3 AE6 AEBDS AENEX AFBFQ AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK C45 CS3 DIK DIWNM DU5 E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OB3 ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH ZB8 .3C .55 .GJ 3O- A9M AAQQT AAYJJ AAYXX ACCJW ADFPA ADGHP ADNKB AEETU AFFNX AHRYX AJNYG BS7 CITATION DUNZO FW0 H13 M18 N4W N~M OCUKA ODA ORVUJ OUVQU P-K R58 T8P X7M YHZ YQJ YYP ZGI ZZMQN |
ID | FETCH-LOGICAL-c898-3cd4735416a58ae9ba9622b24712b0fa77eb958220243feb9df062f08c891be53 |
ISSN | 0039-2499 |
IngestDate | Tue Jul 01 01:49:01 EDT 2025 Fri May 16 03:49:15 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c898-3cd4735416a58ae9ba9622b24712b0fa77eb958220243feb9df062f08c891be53 |
ParticipantIDs | crossref_primary_10_1161_str_52_suppl_1_P533 wolterskluwer_health_00007670-202103001-00588 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210301 2021-03-00 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 3 year: 2021 text: 20210301 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Stroke (1970) |
PublicationYear | 2021 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
SSID | ssj0002385 |
Score | 2.3554125 |
Snippet | BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and... Abstract only Background: Hematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not... |
SourceID | crossref wolterskluwer |
SourceType | Index Database Publisher |
StartPage | AP533 |
Title | Abstract P533: Incidence and Outcomes of Thrombectomy Rescue Therapies in Acute Basilar Artery Occlusions |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00007670-202103001-00588 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQlzFuMkPvI2U1I0Tm7cMgSa0cRFF21vkJM6I1iVVLkLwj_iXnGOnqSuKxHiJ0rSxE5-v9ufjz-cQ8oLrTBRhDtNUpaQXqDzzpJ8Jr-BBESAFj3zc4HzyITz6Grw_42eTyS9HtdR36TT7uXNfyf9YFa6BXXGX7BUsOxYKF-Ac7AtHsDAc_8nGcYqOiqw7-AR0Cuf28G-3SULNmsDHvoNabVTZxbemvkzRRX-JrLvNeo1qi0atSiPJOogzVAwcqrZEXWqMSs8fGIN42bejS28gsV-6pr4w3HQmI9_xJRz3dkZfO_P8U7UchBu4HWaT5PlUl62Nu6Ab77i0qmZHYY-xIFe6Oe_NF4e6gTetctdJwRyVlnVS7Ag2YZwU5RKVQG4HPccFH5szad1Bc-YA0SQ7TWZOnxtjGzsD-Pj5z9EhxNEBLDPlDMYmU9B0c_dW2G2zxhtGvoevA6BFr4vPhbhGrrMIaBqu_3_eBKYH5mOTZQzPPwS4ghpf7ahviwTd-l6jMKK9MPsiHHazuENuD9MSGluM3SUTXd0jN04G4cV9Uq6hRrHg13QEGgWj0DXQaF1QF2jUAo2OQKNlRQ3Q6AA0aoFGN0B7QBbv3i7eHHlDlg4vE1J48yzH7NXA6xUXSstUyZCxlAHpYalfqCjSqeRAQzH0ZQHneeGHrPAF3D1LNZ8_JHtVXelHhIowFEwCgcwKE7VISKl9jQmJQh7oXO6Tl-tWS1Y2Fkti5rDhLIE2SDhLhkZOsC32ibfVsondWZz8zbKPr_j7J-TmBupPyV7X9PoZMNQufW6w8RvUZo28 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+P533%3A+Incidence+and+Outcomes+of+Thrombectomy+Rescue+Therapies+in+Acute+Basilar+Artery+Occlusions&rft.jtitle=Stroke+%281970%29&rft.au=Lun%2C+Ronda&rft.au=Walker%2C+Greg+B&rft.au=Weisenburger-Lile%2C+David&rft.au=Lapergue%2C+Bertrand&rft.date=2021-03-01&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0039-2499&rft.volume=52&rft.issue=Suppl_1&rft.spage=AP533&rft.epage=AP533&rft_id=info:doi/10.1161%2Fstr.52.suppl_1.P533&rft.externalDocID=00007670-202103001-00588 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |